Pfizer Suspends Popular Menopause Cream in India
A Premarin shortage in India leaves menopausal patients facing limited treatment options as Pfizer halts cream distribution.
Pfizer stopped selling a popular menopause cream in India because they don't have enough to supply. When a company can't deliver products people need, it can signal supply problems that might affect their business in that region.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.